From: Paradoxical role of hepatocyte growth factor in ischemic stroke: stroke risk/stroke recovery
The patient group | Test U | P value | |||
---|---|---|---|---|---|
Carotid atherosclerosis N = 50 | Cardioembolic N = 50 | Total N = 100 | |||
IMT | |||||
X ± SD | 2.27 ± 1.26 | 0.60 ± 0.14 | 1.44 ± 1.22 | 8.6 | < 0.001* |
Range | 0.90–5 | 0.3–0.80 | 0.3–5 |
No | % | No | % | X2 | ||||
---|---|---|---|---|---|---|---|---|
Atherosclerosis severity | ||||||||
No (IMT ≤ 0.8 mm) | 0 | 0 | 50 | 100 | 50 | 50 | 100 | < 0.001* |
Mild (IMT 0.9–1 mm) | 11 | 22 | 0 | 0 | 11 | 11 | ||
Moderate (IMT 1.1–1.9 mm) | 17 | 34 | 0 | 0 | 17 | 17 | ||
Severe (IMT ≥ 2 mm) | 22 | 44 | 0 | 0 | 22 | 22 |